These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 33675684)

  • 1. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.
    Gratuze M; Leyns CE; Sauerbeck AD; St-Pierre MK; Xiong M; Kim N; Serrano JR; Tremblay MÈ; Kummer TT; Colonna M; Ulrich JD; Holtzman DM
    J Clin Invest; 2020 Sep; 130(9):4954-4968. PubMed ID: 32544086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
    Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
    Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
    Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
    Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways.
    Ibanez KR; McFarland KN; Phillips J; Allen M; Lessard CB; Zobel L; De La Cruz EG; Shah S; Vo Q; Wang X; Quicksall Z; Ryu D; Funk C; Ertekin-Taner N; Prokop S; Golde TE; Chakrabarty P
    Alzheimers Res Ther; 2022 Jul; 14(1):104. PubMed ID: 35897046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 8. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
    Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
    Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of TREM2 facilitates tau accumulation, spreading, and brain atrophy, but only in the presence of amyloid pathology.
    Haass C
    Neuron; 2021 Apr; 109(8):1243-1245. PubMed ID: 33887187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.
    Jay TR; Miller CM; Cheng PJ; Graham LC; Bemiller S; Broihier ML; Xu G; Margevicius D; Karlo JC; Sousa GL; Cotleur AC; Butovsky O; Bekris L; Staugaitis SM; Leverenz JB; Pimplikar SW; Landreth GE; Howell GR; Ransohoff RM; Lamb BT
    J Exp Med; 2015 Mar; 212(3):287-95. PubMed ID: 25732305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo.
    Lee-Gosselin A; Jury-Garfe N; You Y; Dabin L; Soni D; Dutta S; Rochet JC; Kim J; Oblak AL; Lasagna-Reeves CA
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TREM2 in Alzheimer's Disease: A Long Road Ahead.
    Kulkarni B; Kumar D; Cruz-Martins N; Sellamuthu S
    Mol Neurobiol; 2021 Oct; 58(10):5239-5252. PubMed ID: 34275100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy.
    Sayed FA; Telpoukhovskaia M; Kodama L; Li Y; Zhou Y; Le D; Hauduc A; Ludwig C; Gao F; Clelland C; Zhan L; Cooper YA; Davalos D; Akassoglou K; Coppola G; Gan L
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10172-10177. PubMed ID: 30232263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
    Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
    Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
    Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
    J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent hypoxia training enhances Aβ endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer's disease.
    Wang X; Xie Y; Fan X; Wu X; Wang D; Zhu L
    Alzheimers Res Ther; 2024 Jun; 16(1):121. PubMed ID: 38831312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
    Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
    Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
    Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.